The forecast for blood and blood-forming organs medicine sales in the UK from 2024 to 2028 shows a consistent increase in per capita sales (in US Dollars PPP), indicating positive growth trends in this segment. Year-on-year variations reveal an upward trend, with projected annual increases around 3% each year. By 2028, there is a forecasted increase to 39.6, up from 35.3 in 2024. The compound annual growth rate (CAGR) stands approximately at 2.9% over these five years.

Future trends to watch for include:

The impact of new therapeutic innovations and potential pricing pressures due to healthcare policies.
Advancements in personalized medicine and targeted therapies may drive demand and influence market dynamics significantly.
Economic fluctuations and currency adjustments could affect pricing and sales trends.